Body composition in lipoedema of the legs using dual‐energy X‐ray absorptiometry: a case–control study
R. Dietzel,A. Reißhauer,S. Jahr,D. Calafiore,G. Armbrecht
DOI: https://doi.org/10.1111/bjd.13697
IF: 11.113
2015-08-01
British Journal of Dermatology
Abstract:DEAR EDITOR, Lipoedema of the legs is a chronic disorder of adipose tissue, characterized by bilateral, symmetric lower extremity enlargement due to subcutaneous deposition of fat which occurs almost exclusively in women. The excess fat deposit usually extends from the waist to a distinct line just above the ankles, while the feet are much less involved or entirely spared. Patients complain about easy bruising and tenderness of the disproportionately enlarged legs, which can lead to severe pain and distinctly impaired mobility. In an advanced state of lipoedema, more than 50% of the affected women develop a generalized obesity, further contributing to impairment in the activities of daily living. The prevalence estimates based on data from specialized lymphology clinics vary from 10–15% to 39%, depending on the diagnostic criteria used. The underlying aetiology of lipoedema remains unknown. Contributing factors reported in the literature include hereditary causes, hormones, adipose cell function and abnormalities in vasculature. Dual-energy X-ray absorptiometry (DXA) is capable of measuring regional body composition (BC) providing information about fat mass, lean mass and bone mass for both total body and subregions. The purpose of this study was (i) to test our hypothesis that DXA-derived BC measures can differentiate lipoedema of the legs from healthy controls and (ii) to provide appropriate cut-off values for meaningful BC measures so as to discriminate between lipoedema of the legs and controls, independent of body mass and in a quick and precise way. Forty-nine women, aged 18–60 years, with lipoedema were recruited from a specialized lymphology clinic in the Department of Rehabilitation and Physical Therapy, Charit e University Hospital, Berlin, Germany. Diagnostic criteria included (i) bilateral and symmetrical enlargement of the legs with sparing of the feet, (ii) pain, tenderness and easy bruising, (iii) minimal pitting oedema and (iv) none or minimal effect of elevation of the extremities or weight loss. Seventy-eight healthy women, aged 20–60 years, were randomly chosen as controls from a population-based, cross-sectional study collecting reference values for BC. Controls were group-matched for body mass index (BMI) categories (normal: BMI 18 5–24 9; overweight: BMI 25–29 9; obese: BMI ≥ 30) at a ratio of 2:1 to cases. The entry criteria for the study excluded those with invalid estimates of BC due to the presence of metal implants or artificial prostheses, oedema or medications affecting water–mineral homeostasis, inability to walk without a walking aid, pregnancy or an inability to understand the nature of the study and follow the instructions. All subjects received a body composition assessment with DXA on the same device (Lunar Prodigy Advance, enCORE Software v9.3; GE Medical Systems Lunar, Europe, Diegem, Belgium). Relative body composition measures were derived by adjusting fat mass and lean mass (kg) of the trunk and leg to BMI (kg m 2). The distribution of fat mass was assessed by creating the ratio of legs fat mass (kg): trunk fat mass (kg) (leg–trunk index) and the ratio of android fat mass (kg): gynoid fat mass (kg) (android–gynoid index). To ensure comparability, both indices were adjusted for BMI. The amount of fat adjusted for BMI in the legs and in the gynoid region was significantly higher in the lipoedema group compared with the control group (Table 1). These findings are consistent across all BMI categories, indicating a constant difference independent of the grade of additional obesity. Across all BMI categories, fat mass of the legs adjusted for BMI was around 1 3 times higher in lipoedema subjects than in healthy reference subjects. The analysis of fat mass of the legs adjusted for BMI as an indicator of lipoedema resulted in an area under the curve (AUC) of 0 82 [95% confidence interval (CI) 0 75– 0 90] (Table 2). The optimal cut-off value for legs fat mass per BMI to identify lipoedema was 0 46 and might be helpful for differential diagnosis in otherwise uncertain cases. The ratio of legs to trunk fat mass as well as the ratio of android to gynoid fat mass, reflecting abnormalities in fat distribution, showed significant differences in subjects with normal and overweight BMI, but not in those who were obese. Likewise, the AUC was 0 71 (95% CI 0 61–0 81) for the leg– trunk index and 0 70 (95% CI 0 60–0 80) for the android– gynoid index, indicating only a moderate discriminative power between healthy subjects and those with lipoedema, especially when the lipoedema of the legs is accompanied by obesity. Given that only very few specific criteria for diagnosis of lipoedema exist, the diagnosis mostly depends upon the clinical experience of the physician. However, sometimes classical clinical signs like filling of the retromalleolar sulcus as well as a disproportionate deposition of adipose tissue at the legs can be hidden by the presence of additional obesity. In these cases, the cut-off value of 0 46 legs fat mass (kg) adjusted for BMI may be suitable to strengthen the diagnosis as it allows separation of lipoedema of the legs from healthy controls regardless of obesity. Future research should focus on estab-